Stemolecule™ iPS Cell Enhancer

Stemolecule™ iPS Cell Enhancer Set详细信息：
Product Overview



The Stemolecule™ iPS Cell Generation Enhancer Set is composed of four small molecules which have been proven to improve iPS cell generation. Stemolecules™ RG108, BIX01294, Valproic Acid, and R(+)Bay K 8644 have been shown to enhance reprogramming efficiencies of viral vectors and recombinant proteins via modulation of epigenetic regulation or L-type Ca2+ channel activity.

Product Specifications

Stemolecule™ iPS Cell Enhancer SetKit / Set Components
Stemolecule™ RG108 (Cat.No.04-0001)
Stemolecule™ BIX01294 (Cat.No.04-0002)
Stemolecule™ Valproic Acid (Cat.No.04-0007)
Stemolecule™ R(+)Bay K 8644 (Cat.No.04-0013)
Lot Number 1259
Set Components 1. StemoleculeTM RG108 (Cat. No. 04-0001), 10 mg, Lot# 1198
2. StemoleculeTM BIX1294 (Cat. No. 04-0002), 5 mg, Lot# 1199
3. StemoleculeTM Valproic Acid (Cat. No. 04-0007), 5 g, Lot# 1090
4. StemoleculeTM R(+)Bay K 8644 (Cat. No. 04-0014), 5 mg, Lot# 1053
Storage Store at -20°C. Protect from light. Following reconstitution, store aliquots at -20°C.
Quality control The purity of Stemgent’s Stemolecules™ was determined by HPLC analysis. The accurate mass and structure of Stemgent’s Stemolecules™ were determined by mass spectrometry and NMR, respectively. Cellular toxicity of Stemgent’s Stemolecules™ was tested on mouse embryonic stem cells.
Stemolecule™ iPS Cell Enhancer SetStability Components are stable for 6 months from date of receipt when stored as directed.
Recommended Usage Refer to individual Stemolecule™ specification sheet.
Notice to Purchaser Purchaser represents and warrants that it will use the Stemolecule™ iPS Cell Generation Enhancer Set purely for research purposes. Not for diagnostic use, not for resale, and not for use in humans or veterinary applications. Stemgent will not be held responsible for patent infringement or other violations that may occur with the use of our products.
Related Products
Stemolecule™ MAPK Signaling Pathway Modulator Set (Cat.No.00-0041)
Stemolecule™ Epigenetic Modifier Set (Cat.No.00-0039)
Stemolecule™ TGF-beta Signaling Pathway Modulator Set (Cat.No.00-0038)
Stemolecule™ ROCK Signaling and Survival Pathway Set (Cat.No.00-0057)
Stemolecule™ Wnt Signaling Pathway Set (Cat.No.00-0059)
Stemolecule™ SHH Signaling Pathway Modulator Set (Cat.No.00-0058)
Stemolecule™ iPS Cell Enhancer Set
xy11782 (卵巢癌细胞,HO-8910细胞
xy11783 (急性粒细胞白血病细胞) HL-60?细胞
xy11784 (肝癌细胞,SK-HEP-1细胞
xy11785 (膀胱鳞癌细胞,SCaBER细胞
xy11786 ( 胚肾细胞,)? AAV-293细胞
xy11787 转化的非洲绿猴肾细胞,COS-7(SV40细胞
xy11788 中国仓鼠卵巢细胞,CHO细胞
xy11789 乳腺管癌 T47-D细胞
xy11790 人正常皮肤细胞,Hacat细胞
xy11791 人胃腺癌细胞（低分化） Human BGC-823细胞
xy11792 人乳腺导管癌细胞,BT474细胞
xy11793 人前列腺正常细胞,rwpe2细胞
xy11794 人胚肾细胞,293 [HEK-293] 细胞
xy11795 人结肠癌细胞,HCT-8细胞
xy11796 人肝癌细胞,hep 3B细胞
xy11797 回盲肠腺癌 HCT-8细胞
xy11798 骨髓瘤细胞株 U266细胞
xy11799 肝转移癌 HCCLMS细胞
xy11800 分泌A2抗体B淋巴细胞,BB7.2细胞
xy11801 低分化胃腺癌 BGC-823细胞
xy11802 大鼠肾细胞,NRK-52E细胞
xy10001 组织细胞淋巴瘤细胞,U-937细胞
xy10002 总T淋巴细胞,OKT3细胞
xy10003 紫色直丝链霉菌
xy10004 紫红曲霉
xy10005 子宫内膜腺癌细胞,HEC-1-B细胞
xy10006 子宫内膜癌 Ishikawa细胞
xy10007 子宫鳞癌细胞（高分化）HCC 94 [HCC941122]细胞
xy10008 子宫颈癌细胞,SiHa细胞
xy10009 转移胰腺腺癌细胞,AsPC-1细胞
xy10010 转血小板基因仓鼠卵巢细胞,CHO-pt细胞
xy10011 转入Tet-off调控，含EGFP基因的CHO细胞,CHO-AA8细胞
xy10012 转染了tk基因的SW038-C2细胞,SW038-C2-tk细胞
xy10013 转染了microRNA-mock基因的阴性对照细胞,Hela-mock细胞
xy10014 转基因细胞,3T3/Fas/com细胞
xy10015 转基因鼻咽癌细胞系 CNE1-lmp\l细胞
xy10016 转化的豚鼠胎体细胞,104C1细胞
xy10017 转S9基因仓鼠卵巢细胞,ZA6细胞
xy10018 转S9基因仓鼠卵巢细胞,ZA1细胞
xy10019 转PYTL基因小鼠睾丸支持细胞,15P-1细胞
xy10020 转HLA-2基因B细胞,T2细胞